Interferon-alpha (IFN-α) enhances cytotoxicity in healthy volunteers and chronic hepatitis C infection mainly by the perforin pathway

被引:0
|
作者
Kaser, A [1 ]
Enrich, B [1 ]
Ludwiczek, O [1 ]
Vogel, W [1 ]
Tilg, H [1 ]
机构
[1] Univ Innsbruck Hosp, Dept Med, Div Gastroenterol & Hepatol, A-6020 Innsbruck, Austria
来源
CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 1999年 / 118卷 / 01期
关键词
interferon-alpha; hepatitis C infection; cytotoxicity; perforin; Fas ligand;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cell-mediated cytotoxicity is exerted via perforin and Fas ligand (FasL). We have recently shown that IFN-alpha up-regulates Fast expression in T cells isolated from healthy volunteers and augments activation-induced T cell death. Since the Fas/FasL system is implicated in the pathogenesis of hepatic failure and both molecules have been shown to be up-regulated in hepatitis C virus (HCV) infection, we studied whether cytotoxicity via the Fast system is enhanced by IFN-alpha and therefore could contribute to hepatic injury. We investigated Fast and perforin expression in peripheral blood mononuclear cells (PBMC) derived from HCV+ donors by Northern analysis and soluble Fast synthesis by ELISA. Natural killer (NK) cell and cytotoxic T lymphocyte (CTL) cytotoxicity was studied by Cr-51-release assays. IFN-alpha up-regulates Fast mRNA and protein synthesis in mitogen-activated PBMC of HCV+ individuals, as previously found in healthy subjects. Stimulation with IFN-alpha increases perforin mRNA levels in PBMC. In NK cytotoxicity assays, the enhancement of cytotoxicity by IFN-alpha is mainly due to the perforin pathway, while the Fast pathway plays only a minor role. In CTL cytotoxicity experiments neither the Fast nor the perforin pathway is further enhanced by IFN-alpha. Our data suggest that upregulation of perforin by IFN-alpha results in elevated cytotoxicity, suggesting that IFN-alpha might support elimination of virally infected cells via this pathway. In contrast, the major effect of IFN-alpha on the Fas/FasL system might be the enhanced elimination of activated T cells as a means of finally limiting a T cell response.
引用
收藏
页码:71 / 77
页数:7
相关论文
共 50 条
  • [21] LATE COMPLETE AND SUSTAINED RESPONSE TO INTERFERON-ALPHA (IFN) THERAPY IN PATIENTS WITH CHRONIC HEPATITIS-C VIRUS (HCV) INFECTION
    ORITO, E
    MIZOKAMI, M
    SUZUKI, N
    OHBA, K
    OHNO, T
    MIZOGUCHI, N
    KOIDE, T
    TERASHIMA, H
    NAKANO, T
    IINO, S
    LAU, JYN
    HEPATOLOGY, 1994, 20 (04) : A159 - A159
  • [22] Granulomatous hepatitis in a patient with chronic hepatitis C treated with interferon-alpha
    Veerabagu, MP
    Finkelstein, SD
    Rabinovitz, M
    DIGESTIVE DISEASES AND SCIENCES, 1997, 42 (07) : 1445 - 1448
  • [23] DISCREPANCY BETWEEN VIROLOGICAL AND BIOCHEMICAL RESPONSE TO INTERFERON-ALPHA (IFN) THERAPY IN CHRONIC HEPATITIS-C VIRUS (HCV) INFECTION
    LAU, JYN
    DAVIS, GL
    OHNO, T
    DIAMOND, D
    KNIFFEN, J
    QIAN, KP
    MIZOKAMI, M
    HEPATOLOGY, 1993, 18 (04) : A88 - A88
  • [24] Systemic sarcoidosis during interferon-alpha therapy for chronic hepatitis C virus infection
    Cacoub, P
    Sbaï, A
    Francès, C
    Génesti, C
    Hausfater, P
    Piette, JC
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2000, 24 (03): : 364 - 366
  • [25] ONE YEAR INTERFERON-ALPHA (IFN-A) TREATMENT OF CHRONIC HEPATITIS NANB
    FERENCI, P
    VOGEL, W
    HENTSCHEL, E
    PRISTAUTZ, H
    FIEDLER, R
    JUDMAIER, G
    KREJS, GJ
    GANGL, A
    HEPATOLOGY, 1991, 14 (04) : A72 - A72
  • [26] Retreatment with interferon-alpha and ribavirin in primary interferon-alpha non-responders with chronic hepatitis C
    Teuber, G
    Berg, T
    Hoffmann, RM
    Leifeld, L
    Lafrenz, M
    Spengler, U
    Pape, GR
    Hopf, U
    Zeuzem, S
    DIGESTION, 2000, 61 (02) : 90 - 97
  • [27] Interferon-alpha therapy and the IL-18 pathway in chronic hepatitis C patients: IFN-alpha therapy enhances circulating IL-18 binding protein levels
    Kaser, A
    Vogel, W
    Novick, D
    Rubinstein, M
    Dinarello, CA
    Tilg, H
    GASTROENTEROLOGY, 2001, 120 (05) : A568 - A568
  • [28] COMPARISON OF BIOLOGICAL EFFECTS OF INTERFERON-ALPHA (IFN) IN NORMAL SUBJECTS AND PATIENTS WITH CHRONIC HEPATITIS-C
    VOGEL, W
    TILG, H
    JUDMAIER, G
    HEROLD, M
    AULITZKY, WE
    HUBER, C
    HEPATOLOGY, 1990, 12 (04) : 849 - 849
  • [29] INTERFERON-ALPHA IS EFFECTIVE IN THE TREATMENT OF CHRONIC HEPATITIS-C
    WORMAN, HJ
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1995, 90 (04): : 679 - 680
  • [30] Human leucocyte interferon-alpha in the treatment of chronic hepatitis C
    Mazzoran, L
    Zorat, F
    Chemello, L
    Crocè, LS
    Rigato, I
    Cavalletto, L
    Bernardinello, E
    Tiribelli, C
    Alberti, A
    Pozzato, G
    DIGESTIVE AND LIVER DISEASE, 2001, 33 (04) : 347 - 352